PROEHL GERALD T (Pres., CEO and Chairman) received a stock award from DERMATA THERAPEUTICS, INC.

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 1 award

PROEHL GERALD T

Filed: 8/18/2026ACC: 0001493152-26-039048

InsiderPROEHL GERALD TCIK 1279191

→

IssuerDERMATA THERAPEUTICS, INC.CIK 1853816

Officer10% Owner· Pres., CEO and Chairman

Since Aug 2021

+4.59M

Net shares

Net buyer

$0.00

Total acquired

Open market trades

0B · 0S

Total transactions

4.59M acquired

Non-Derivative Transactions1

Common Stock

Indirect

A · Award

+170.07K

Price / share

—

Trade value

—

% of position

138.8%

8/16/2026

122.56K→292.63K

Total

Net shares

+170.07K

Net value

$0.00

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Indirect	8/16/2026	A · Award	+170.07K	—	—	138.8%	122.56K	292.63K
Total			+170.07K		$0.00

Derivative Transactions5

Series E Warrant (Right to Buy)

Indirect

A · Award

Converts to

Common Stock

1.36M shares

+1.36M

Strike price

1.47

Held after

1.36M

Exercisable

—

8/16/2026

Series F Warrant (Right to Buy)

Indirect

A · Award

Converts to

Common Stock

1.36M shares

+1.36M

Strike price

1.47

Held after

1.36M

Exercisable

—

8/16/2026

Series E Warrant (Right to Buy)

Indirect

A · Award

Converts to

Common Stock

170.07K shares

+170.07K

Strike price

1.47

Held after

170.07K

Exercisable

—

8/16/2026

Series F Warrant (Right to Buy)

Indirect

A · Award

Converts to

Common Stock

170.07K shares

+170.07K

Strike price

1.47

Held after

170.07K

Exercisable

—

8/16/2026

Pre-Funded Warrant (Right to Buy)

Indirect

A · Award

Converts to

Common Stock

1.36M shares

+1.36M

Strike price

.001

Held after

1.36M

Exercisable

—

8/16/2026

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Series E Warrant (Right to Buy) Indirect	Common Stock1.36M shares	8/16/2026	A · Award	+1.36M	1.47	—	1.36M
Series F Warrant (Right to Buy) Indirect	Common Stock1.36M shares	8/16/2026	A · Award	+1.36M	1.47	—	1.36M
Series E Warrant (Right to Buy) Indirect	Common Stock170.07K shares	8/16/2026	A · Award	+170.07K	1.47	—	170.07K
Series F Warrant (Right to Buy) Indirect	Common Stock170.07K shares	8/16/2026	A · Award	+170.07K	1.47	—	170.07K
Pre-Funded Warrant (Right to Buy) Indirect	Common Stock1.36M shares	8/16/2026	A · Award	+1.36M	.001	—	1.36M

Non-Derivative Holdings (Post-Transaction)4

Common Stock

Indirect

Shares owned7.00

Common Stock

Indirect

Shares owned3.00

Common Stock

Direct

Shares owned24.00

Common Stock

Indirect

Shares owned79.95K

Total

24.00 direct·79.96K indirect79.98K

Security Title	Shares Owned	Ownership Type
Common Stock	7.00	Indirect
Common Stock	3.00	Indirect
Common Stock	24.00	Direct
Common Stock	79.95K	Indirect
Total	79.98K	24.00 direct·79.96K indirect

Derivative Holdings (Post-Transaction)0

No derivative holdings reported